{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "340",
                "348"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Euthyrox"
        },
        {
            "identifier": "T2",
            "position": [
                "350",
                "359"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Cefazolin"
        },
        {
            "identifier": "T3",
            "position": [
                "361",
                "370"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Pyralgina"
        },
        {
            "identifier": "T4",
            "position": [
                "372",
                "393"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Pulmicort (inhalacje)"
        },
        {
            "identifier": "T5",
            "position": [
                "505",
                "539"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "Kontrola w Poradni Kardiologicznej"
        },
        {
            "identifier": "T6",
            "position": [
                "540",
                "553"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "za 3 miesi\u0105ce"
        },
        {
            "identifier": "T7",
            "position": [
                "571",
                "580"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Euthyroxu"
        },
        {
            "identifier": "T8",
            "position": [
                "589",
                "623"
            ],
            "subtype": "Drug_dose",
            "type": "T",
            "value": "18,75ug/dob\u0119 (3/4 tabletki a 25ug)"
        },
        {
            "identifier": "T9",
            "position": [
                "625",
                "662"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "kontrola w Poradni Endokrynologicznej"
        },
        {
            "identifier": "T10",
            "position": [
                "802",
                "821"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "wrodzon\u0105 wad\u0105 serca"
        },
        {
            "identifier": "T11",
            "position": [
                "825",
                "844"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "blokiem III stopnia"
        },
        {
            "identifier": "T12",
            "position": [
                "1121",
                "1140"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "blokiem III stopnia"
        },
        {
            "identifier": "T13",
            "position": [
                "869",
                "889"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "wszczepienia baterii"
        },
        {
            "identifier": "T14",
            "position": [
                "1165",
                "1185"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "wszczepienia baterii"
        },
        {
            "identifier": "T15",
            "position": [
                "1098",
                "1117"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "wrodzon\u0105 wad\u0105 serca"
        },
        {},
        {
            "icd": "ICD10:Q20",
            "identifier": "N1",
            "referenced": "T10",
            "subtype": "Reference",
            "type": "N",
            "value": "Wrodzone wady rozwojowe jam i po\u00c5\u0082\u00c4\u0085cze\u00c5\u0084 sercowych"
        },
        {
            "icd": "ICD10:Q20",
            "identifier": "N2",
            "referenced": "T15",
            "subtype": "Reference",
            "type": "N",
            "value": "Wrodzone wady rozwojowe jam i po\u00c5\u0082\u00c4\u0085cze\u00c5\u0084 sercowych"
        },
        {
            "arg1": "T7",
            "arg2": "T8",
            "identifier": "R1",
            "subtype": "Drg",
            "type": "R"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 8 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: \u017ce\u0144ska\n------------------------------------------------\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nEuthyrox, Cefazolin, Pyralgina, Pulmicort (inhalacje)\n------------------------------------------------\nZalecenia\n------------------------------------------------\n1. Kontrola w Poradni Kardiologicznej za 3 miesi\u0105ce.\n2. Przyjmowanie Euthyroxu w dawce 18,75ug/dob\u0119 (3/4 tabletki a 25ug), kontrola w Poradni Endokrynologicznej.\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nDziewczynka z wrodzon\u0105 wad\u0105 serca  i blokiem III stopnia  przyj\u0119ty do Kliniki do wszczepienia baterii  poszerzonych bada\u0144 i ustalenia dalszego post\u0119powania Stan do\u015b\u0107 dobry\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nDziewczynka z wrodzon\u0105 wad\u0105 serca  i blokiem III stopnia  przyj\u0119ty do Kliniki do wszczepienia baterii  poszerzonych bada\u0144 i ustalenia dalszego post\u0119powania Stan do\u015b\u0107 dobry\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nPotas: K:4.6[mmol/L]\nS\u00f3d: Na:143[mmol/L]\nRKZ Parametry krytyczne\n    pH:7.325\n    pCO2:43.9[mmHg]\n    BE:-3.30[mmol/L]\n    HCO3:22.3[mmol/L]\n    pO2:64.0[mmHg]\n    O2Sat:92.3[%]\n    COMMENT_HL7:\nMorfologia\n    WBC:5.73[10\\\\^3/ul]\n    RBC:4.74[10\\\\^6/ul]\n    HGB:14.6[g/dl]\n    HCT:41.5[%]\n    MCV:87.6[fl]\n    MCH:30.8[pg]\n    MCHC:35.2[g/dl]\n    PLT:283.0[10\\\\^3/ul]\n    RDW-SD:39.6[fl]\n    RDW-CV:12.3[%]\n    PDW:9.8[fl]\n    MPV:9.4[fl]\n    P-LCR:19.5[%]\n    PCT:0.3[%]\n    NEUTR#:2.61[10\\\\^3/ul]\n    NEUTR%:45.6[%]\n    LYMPH#:2.34[10\\\\^3/ul]\n    LYMPH%:40.8[%]\n    MONO#:0.53[10\\\\^3/ul]\n    MONO%:9.20[%]\n    EO#:0.17[10\\\\^3/ul]\n    EO%:3.00[%]\n    BASO#:0.08[10\\\\^3/ul]\n    BASO%:1.40[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nBadanie - Elementy  moczu niewirowanego\n    Erym:2 /uL\u015bw.[ul]\n    Leum:3 /uL[ul]\n    Bakm:pojedyncze[wpw]\n    NabP\u0142m:nieliczne[wpw]\n    Pas\u015al:pojedyncze pasma[wpw]\nBadanie og\u00f3lne moczu\n    Barwa:\u017c\u00f3\u0142ta\n    Przej:zupe\u0142na\n    SG:1.020\n    pH:5.0\n    LEU:nieobecne[ul]\n    NIT:nieobecne[ul]\n    mKET:nieobecne[mg/dl]\n    mURO:niewzmo\u017cona\n    BIL:nieobecna\n    ERY:nieobecna[ul]\n    GLU-mocz:nieobecna[mg/dl]\n    UPROT:nieobecne[mg/dl]\nImmununochemia -Immulite: COMMENT_HL7:\nD-dimery t. ilo\u015bciowy: D-dimer:449.0[ng/ml]\nPLT -  z koagulogramu: PLT-KOAG:283.0[10\\\\^3/ul]\nFibrynogen (F): FIB:2.58[g/L]\nAntytrombina III (ATIII): ATIII:97.0[%]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:29.6[s]\nINR: INR:1.1\nCzas protrombinowy (PT): PT:12.7[s]\nCzas trombinowy (TT): TT:15.4[s]\nChlorki: Cl:105[mmol/L]\nWap\u0144 ca\u0142kowity: Ca:2.44[mmol/L]\nMagnez: Mg:0.79[mmol/L]\nBilirubina ca\u0142kowita TBIL: TBIL:0.55[mg/dl]\nBia\u0142ko CRP: CRP:0.50[mg/dl]\nWska\u017anik PT: PT%:87[%]\nFe: Fe:126.00[ug/dl]\nKreatynina: CREA:0.35[mg/dl]\nMocznik: UREA:26.00[mg/dl]\nASPAT: AST:33.00[IU/L]\nALAT: ALT:32.00[IU/L]\nNT- proBNP: NTpBNP:96.40[pg/ml]\nTSH: TSH:6.60[uIU/ml]\nGlukoza w surowicy: GLU-sur:79[mg/dl]\nPosiew - Wymaz z nosa: POSIEW:\nPosiew - Wymaz z odbytu: POSIEW:\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:135.7[ml/min/1,73m2]\nWzrost pacjenta: WzrostPac:115[cm]\neGFR (1-18r\u017c K) stand.wg.Schwartza  wsp. 0.550: eGFR 1-18K:180.7[ml/min/1,73m2]\nFT3 III: FT3 III:3.59[pg/ml]\nFT4II: FT4II:0.96[ng/dl]\nGrupa krwi + p/c odporno\u015bciowe (powy\u017cej 4. m-ca \u017cycia\n    NR-KS:G-18/012588\n    KODKRESKOWYPROBKI:G-18/012588\n    GR:B\n    RH:- (ujemny)\n    FENOTYP:K-\n    P-CIALA:Przeciwcia\u0142 odporno\u015bciowych dla antygen\u00f3w krwinek czerwonych nie stwierdzono.\n------------------------------------------------\nICD10\n------------------------------------------------\nI44.2\nQ90.9\nQ21.2\nZ98.8\nQ21.1\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n89.00\n88.721\nO69\nG21\nG25\n89.541\nL69\n23.0105\n------------------------------------------------"
}